The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and effectiveness of Peridex (an oral rinse containing chlorhexidine
gluconate) for preventing the occurrence of clinically-evident microbiologically-documented
oral candidiasis in HIV-positive patients, who are at risk of the disease based on previous
history of candidiasis.